ClinicalTrials.gg
CompletedNCT02858115Updated Aug 8, 2016

Use of Mini-fluid Challenge for Fluid Responsiveness Prediction During One-lung Ventilation

An observational study in Acute Circulatory Failure During One-lung Ventilation Surgery, sponsored by Assistance Publique Hopitaux De Marseille. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-08-08.

Sponsored by Assistance Publique Hopitaux De Marseille · Observational

Study type
Observational
Time perspective
Retrospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

During thoracic surgery, an excessive use of fluid results in pulmonary complications. Dynamic fluid responsiveness predictors are not easily usable during one lung ventilation. The investigators hypothesized that the assessment by transesophageal echocardiography (TEE) of subaortic velocity time index (VTI) variation after 100 ml of crystalloid would predict fluid responsiveness in patients receiving one-lung ventilation.

This retrospective, observational, single center study was from January 2014 to December 2015. The investigators included 105 patients requiring one lung ventilation lung resection. The investigators analysed 39 patients presenting an acute circulatory failure. 100 ml of crystalloid was infused over 1-min. After an echocardiographic assessment at 1-min, remaining 400 ml were administered over 14-min Fluid responsiveness was defined as an increase in the VTI above 15% after infusion of 500 ml of crystalloid.

02

Conditions studied

  • Acute Circulatory Failure During One-lung Ventilation Surgery
03

In context

Lead sponsor

Assistance Publique Hopitaux De Marseille is the lead sponsor of 700 studies on the registry; 144 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients requiring one lung ventilation lung resection.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Lung resection
  • Acute circulatory failure
  • One-lung ventilation

Exclusion criteria

Exclusion Criteria:

  • Sinusal rhythm
05

Study design

Time perspective
Retrospective
Enrollment
50 participants (actual)
Patient registry
No

Groups and cohorts

  • one lung ventilation lung

    patients requiring one lung ventilation lung resection.

    Other: Fluid challenge · Other: Trans-oesophageal echography

Interventions

  • OtherFluid challenge

    100 ml of crystalloid was infused over 1-min

  • OtherTrans-oesophageal echography

    an echocardiographic assessment at 1-min,

06

What researchers measure

Primary outcomes

  1. Fluid responsiveness

    increase of cardiac output of more than 15%

    Time frame: one day

  2. Velocity time index

    : Echographic assesment of cardiac output

    Time frame: one day

Secondary outcomes

  1. Pulsed pressure variation

    dynamic indice of fluid responsiveness

    Time frame: one day

07

Study locations

1 site
  • hôpital Nord Assistance Publique Hôpitaux de Marseille
    Marseille, 13015, France
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2014, a primary completion of Dec 2015 and a completion of Aug 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2016
First posted
Aug 8, 2016
Start
Jan 2014
Primary completionActual
Dec 2015
CompletionActual
Aug 2016
Last update
Aug 8, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02858115
Responsible party
Sponsor
First posted
Aug 8, 2016
Start date
Jan 2014
Primary completion
Dec 2015
Completion
Aug 2016
Last update
Aug 8, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion